POSTPONED Taking New Biotherapeutics from Discovery to Clinic – Approaches and Tools to Maximise Success

A one day One Nucleus and Lonza symposium in Cambridge, to gain insight and discuss.

Attendance at this event is complimentary.

This event is primarily focused on early-stage life science innovators, biotechs, companies in bioincubators and translational research groups with an interest in protein expression and approaches/tools to successfully scale.  Please note, all registrations are subject to the approval of the sponsor and registration cancelled if they are not considered to meet the above criteria. You will be informed if your registration has been cancelled within 2 working days of registering online for the event.

One Nucleus is collaborating with Lonza to bring you a complimentary symposium on Wednesday 1 April 2020 at Chesterford Research Park, Cambridge to gain insight from experts, in the different approaches and techniques to successfully progress therapeutic proteins from discovery to the clinic. Enjoy an industry perspective from a seasoned pharmaceutical executive, together with updates to approaches with new and established technologies enabling translational research.

Pre-book 1-on-1 sessions with our scientific experts at the Drop-in-Clinics that will follow the morning presentations. While you wait for your session, enjoy a parallel track featuring presentations from local companies and leading academics.

Our networking lunch offers the opportunity to meet with other delegates, speakers and Lonza specialists.

Agenda
08.30 – 09.00 Delegate Registration, Networking over Tea and Coffee

09.00 – 09.10 Welcome: Tony Jones, CEO, One Nucleus | Sarah Holland, Global Head of Licensing, Lonza

09.10 – 09.45 Keynote : An Industry perspective - What to consider when moving therapeutic proteins from development to first in human trials
Hari Kumar | Pharmaceutical Executive; Independent Board Member; former CEO Adheron Therapeutics

09.45– 10.20 Developability assessment tools and de-risking strategies to support progression of biologics from discovery to development
Yvette Stallwood | Head, Applied Protein Services, Lonza

10.20 – 10.55 Approaches to maximise successful development of cell lines expressing more complex proteins - including bispecific antibodies
Alison Porter | Head of Expression System Sciences, Lonza

10.55 – 11.30 A step forward – combined strategies to enhance the performance of Pichia pastoris
Joachim Klein | Head of Strain Development and Cell Banking, Microbial Development Services, Lonza

11.30 – 11.45 Break and setup for Drop-in-Clinic sessions | Company presentations

11.45 – 13.00 Drop-in-Clinic sessions | Parallel track of presenting companies

     • Meet our scientific experts at drop in sessions for 1-on-1 consultations
     • Parallel track featuring presentations from local companies and leading academics,   

      Presentations include:

       Title tbc

       Dr Ed McGowan, Director of Antibody Discovery & Development, Isogenica

      Antibody discovery, affinity maturation and developability screening from large   

      mammalian display libraries

      Dr John McCafferty, CEO & Founder, IONTAS

13.00 – 14.00 Networking Lunch

14.00 – 15.00 Drop-in-Clinic sessions | Parallel track of presenting companies

    • Meet our scientific experts at drop in sessions for 1-on-1 consultations

    • Parallel session featuring presentations from companies and leading academics

15.00 – 16.00 Networking Drinks and Snacks 

16.00 Delegates Depart

*This button will not work if you are not logged in*